C7ORF25 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.63824509513688E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.52988732793347E-13 |
Normal-vs-Stage2 |
5.66159999999538E-05 |
Normal-vs-Stage3 |
5.00166574823879E-12 |
Normal-vs-Stage4 |
4.24309998248162E-09 |
Stage1-vs-Stage2 |
7.372600E-01 |
Stage1-vs-Stage3 |
4.406400E-01 |
Stage1-vs-Stage4 |
7.992400E-01 |
Stage2-vs-Stage3 |
4.252000E-01 |
Stage2-vs-Stage4 |
8.821400E-01 |
Stage3-vs-Stage4 |
4.193400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.63957736276643E-12 |
Normal-vs-AfricanAmerican |
1.7221499999942E-05 |
Normal-vs-Asian |
1.620080E-02 |
Caucasian-vs-AfricanAmerican |
7.405600E-01 |
Caucasian-vs-Asian |
6.692000E-01 |
AfricanAmerican-vs-Asian |
6.785800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.22044604925031E-15 |
Normal-vs-Female |
2.15899964572941E-10 |
Male-vs-Female |
8.977500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.152700E-04 |
Normal-vs-Age(41-60Yrs) |
1.63535851527286E-12 |
Normal-vs-Age(61-80Yrs) |
1.48037138103518E-12 |
Normal-vs-Age(81-100Yrs) |
1.360550E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.238800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.722200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.463600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.602600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.044600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.651800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.76739999999876E-05 |
Normal-vs-Grade 2 |
4.87032636442564E-12 |
Normal-vs-Grade 3 |
1.83375536977337E-12 |
Normal-vs-Grade 4 |
1.94220000082623E-08 |
Grade 1-vs-Grade 2 |
5.390400E-01 |
Grade 1-vs-Grade 3 |
6.922000E-01 |
Grade 1-vs-Grade 4 |
7.593200E-01 |
Grade 2-vs-Grade 3 |
5.169800E-01 |
Grade 2-vs-Grade 4 |
5.861200E-01 |
Grade 3-vs-Grade 4 |
9.294200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
7.43269890080001E-11 |
Normal-vs-ccB subtype |
1.94233518158171E-12 |
ccA subtype-vs-ccB subtype |
4.247700E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
8.17812484399383E-12 |
Normal-vs-N1 |
2.365300E-04 |
N0-vs-N1 |
9.163800E-01 |
|
|